BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 12677504)

  • 1. [Prospective analysis of quantification of contrast media enhanced power Doppler sonography of equivocal breast lesions].
    Pudszuhn A; Marx Ch; Malich A; Fleck M; Schneider A; Kaiser WA
    Rofo; 2003 Apr; 175(4):495-501. PubMed ID: 12677504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions.
    Kook SH; Kwag HJ
    J Clin Ultrasound; 2003 Jun; 31(5):227-38. PubMed ID: 12767017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US--early experience.
    Huber S; Helbich T; Kettenbach J; Dock W; Zuna I; Delorme S
    Radiology; 1998 Aug; 208(2):485-9. PubMed ID: 9680580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of vascularity in breast tumors--comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging].
    Schröder RJ; Bostanjoglo M; Hidajat N; Rademaker J; Röttgen R; Mäurer J; Felix R
    Rofo; 2002 Sep; 174(9):1132-41. PubMed ID: 12221572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What is the role of Doppler color sonography associated with echo-signal enhancing levovist in complementary breast diagnosis?].
    Grüner C; Schönwälder A; Schulz-Wendtland R; Lang N; Bautz W
    Aktuelle Radiol; 1998 Mar; 8(2):58-62. PubMed ID: 9592578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ultrasonography contrast media Levovist and power Doppler in the study of the breast. Methodology, vascular morphology and automatic enhancement quantification with wash-in and wash-out curves].
    Menna S; Di Virgilio MR; Burke P
    Radiol Med; 1999 Jun; 97(6):472-8. PubMed ID: 10478204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent-initial experience.
    Moon WK; Im JG; Noh DY; Han MC
    Radiology; 2000 Oct; 217(1):240-6. PubMed ID: 11012451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of signal-enhanced color Doppler ultrasound in space-occupying lesions of the skin and skin appendages].
    Schröder RJ; Mäurer J; Hidajat N; Zlowodski M; Schlums D; Weber S; Hosten N; Felix R
    Rofo; 1999 Sep; 171(3):211-8. PubMed ID: 10520331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between color power Doppler sonographic measurement of breast tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis.
    Yang WT; Tse GM; Lam PK; Metreweli C; Chang J
    J Ultrasound Med; 2002 Nov; 21(11):1227-35. PubMed ID: 12418764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamic assessment of contrast medium enhancement in Doppler ultrasound imaging. Current status].
    Huber S; Delorme S; Zuna I
    Radiologe; 1998 May; 38(5):390-3. PubMed ID: 9646345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress.
    Kedar RP; Cosgrove D; McCready VR; Bamber JC; Carter ER
    Radiology; 1996 Mar; 198(3):679-86. PubMed ID: 8628854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROC curve analysis in the evaluation of contrast-enhanced color Doppler US.
    Winehouse J; Douek M; Lees W
    Radiology; 1999 Sep; 212(3):911-2. PubMed ID: 10478265
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of enhanced Doppler ultrasound in differentiation of benign vs. malignant scar lesion after breast surgery for malignancy.
    Bäz E; Madjar H; Reuss C; Vetter M; Hackelöer B; Holz K
    Ultrasound Obstet Gynecol; 2000 May; 15(5):377-82. PubMed ID: 10976477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity.
    Forsberg F; Kuruvilla B; Pascua MB; Chaudhari MH; Merton DA; Palazzo JP; Goldberg BB
    Ultrasound Med Biol; 2008 Sep; 34(9):1365-72. PubMed ID: 18436369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
    Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
    Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Precompression on the Power Doppler Assessment of Breast Lesion Vascularity.
    DeVita R; Barr RG
    J Ultrasound Med; 2017 Feb; 36(2):243-247. PubMed ID: 27925701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vascularization of breast tumors: use of ultrasound contrast medium in evaluating tumor entity. Preliminary results].
    Stuhrmann M; Aronius R; Roefke C; Schietzel M
    Rofo; 1998 Oct; 169(4):360-4. PubMed ID: 9819647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography.
    Stuhrmann M; Aronius R; Schietzel M
    AJR Am J Roentgenol; 2000 Dec; 175(6):1585-9. PubMed ID: 11090380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contrast enhanced power Doppler and color Doppler ultrasound in breast masses: Efficiency in diagnosis and contributions to differential diagnosis].
    Algül A; Balci P; Seçil M; Canda T
    Tani Girisim Radyol; 2003 Jun; 9(2):199-206. PubMed ID: 14661490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced power Doppler sonography in breast lesions: effect on differential diagnosis after mammography and gray scale sonography.
    Zdemir A; Kiliç K; Ozdemir H; Yücel C; Andaç S; Colak M
    J Ultrasound Med; 2004 Feb; 23(2):183-95; quiz 196-7. PubMed ID: 14992355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.